Stifel raises Texas Instruments stock price target on revenue beat

Texas Instruments reported Q1 2026 revenue of $4.83 billion, beating Stifel’s $4.50 billion estimate by 7.2%, and guided Q2 revenue to $5.20 billion, above Stifel’s prior $4.82 billion view. Stifel raised its price target to $290 from $250 while reiterating Buy, citing the company’s move into a next analog upcycle, improving margins, and growth in data center end markets. The stock is up 60% over the past year and trades near its 52-week high of $238.80.

Analysis

TXN looks less like a one-quarter beat and more like an inflection in the analog cycle with a catch-up phase still ahead. The bigger signal is not the size of the upside revision, but that improving mix and utilization are arriving while the company is still in the midst of a heavy capex payoff period, which should mechanically expand FCF leverage over the next 2-6 quarters if demand holds.

The market is likely underappreciating the second-order effect of inventory normalization across industrial and data-center channels: once customers move from destocking to replenishment, analog names often see a multi-quarter earnings acceleration that outlasts the initial revenue rebound. That said, the setup is already crowded on quality-factor ownership, and the stock’s multiple is now assuming a fairly clean glide path in margins and capital intensity, leaving less room for any pause in order growth or a slower-than-expected recovery in auto/industrial end demand.

From a positioning standpoint, TXN is a cleaner expression of cyclical analog recovery than the broader semiconductor complex because it has direct operating leverage to analog utilization and a shareholder-return narrative that supports valuation. The contrarian risk is that the market may be extrapolating the data-center contribution too aggressively; if that growth normalizes from very high rates, the stock can still de-rate even with decent fundamentals. For Barclays, the upgrade matters less for the name itself than for signaling that investor skepticism around industrial demand is now becoming a consensus unwind.

Key Decisions for Investors

• Add TXN on pullbacks over the next 1-3 weeks; target a 6-12 month hold with upside toward the revised valuation band, but trim if the stock re-rates above ~30x forward free cash flow without another estimate raise.
• Pair trade: long TXN / short a higher-beta analog peer basket over 1-2 quarters to express the view that large-cap analog with capital returns wins as the cycle heals, while weaker balance-sheet names lag on slower FCF inflection.
• Sell downside protection via TXN put spreads 2-3 months out if implied vol remains elevated; thesis is limited near-term downside unless industrial momentum rolls over abruptly.
• Use TXN strength to hedge cyclicals elsewhere: if industrial PMIs stall, TXN should hold up better than autos/chemicals, making it a relative-long in a slowdown tape.
• Avoid chasing at current levels if you need a clean risk/reward entry; wait for a 5-8% retracement or confirmation that Q2 guide is being revised higher by additional sell-side models before adding size.